New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

New Meds and Tech: Freestyle Libre 2

Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…

COVID-19 Resources

These resources have been identified by members as being useful during these difficult times. They are provided as a reference only. Timely information about COVID-19 that…

COVID-19 Resources Related to Endocrinology and Diabetes

New Meds and Tech: Riomet ER™

Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in…

Child with Suspected Rickets

Primary Care provider guidelines for referral.

Child with Suspected Klinefelter Syndrome

Primary Care provider guidelines for referral.

Infant with Suspected Hyperthyroidism

Primary Care provider guidelines for referral.

Infant with Suspected Congenital Hypothyroidism

Primary Care provider guidelines for referral.

Child with Suspected Hyperglycemia

Primary Care provider guidelines for referral.